Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4)

Journal of Biological Chemistry

Volumn 288, Issue 6, 2013, Pages 4076-4084

  Li, Sheng ^a   Zhou, Qibing ^a   He, Huan ^a   Zhao, Yahui ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CELL CYCLE REGULATION; CELL-CYCLE ARREST; KRUPPEL-LIKE FACTORS; NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION PATHWAYS; THERAPEUTIC STRATEGY; TRANSACTIVATION; TRANSCRIPTIONAL REGULATION; TUMORIGENESIS; UP-REGULATION;

LIGANDS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

CELL DEATH;

KRUPPEL LIKE FACTOR 4; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TRANSCRIPTION FACTOR; TROGLITAZONE;

ARTICLE; ASSAY; BINDING SITE; CELL CYCLE ARREST; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CODON; DNA RESPONSIVE ELEMENT; G1 PHASE CELL CYCLE CHECKPOINT; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; LUCIFERASE REPORTER ASSAY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE, TUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS; PPAR GAMMA; RESPONSE ELEMENTS; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84873663834     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.317487     Document Type: Article

References (33)

1. Vamecq, J., and Latruffe, N. (1999) Medical significance of peroxisome proliferator-activated receptors. Lancet 354, 141-148
2. Kersten, S., Desvergne, B., and Wahli, W. (2000) Roles of PPARs in health and disease. Nature 405, 421-424
3. Lehrke, M., and Lazar, M. A. (2005) The many faces of PPARy. Cell 123, 993-999
4. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994) Stimulation of adipo-genesis in fibroblasts by PPAR72, a lipid-activated transcription factor. Cell 79, 1147-1156
5. Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J. C, Chapman, J., Najib, J., and Staels, B. (1998) Activation of proliferator-activated receptors a and 7 induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273, 25573-25580
6. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. (1998) Ligand for peroxisome proliferator-activated receptor 7 (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58, 3344-3352
7. Takahashi, N, Okumura, T., Motomura, W., Fujimoto, Y., Kawabata, I., and Kohgo, Y. (1999) Activation of PPAR7 inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 455, 135-139
8. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor 7 and the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 237-241
9. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. (1992) Convergence of 9-cis-retinoic acid and peroxisome prolifera-tor signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774
10. 2 is a ligand for the adipocyte determination factor PPAR7. Cell 83, 803-812
11. 1. Life Sci 70, 1565-1575
12. Itami, A., Watanabe, G., Shimada, Y., Hashimoto, Y., Kawamura, J., Kato, M., Hosotani, R., and Imamura, M. (2001) Ligands for peroxisome proliferator-activated receptor 7 inhibit growth of pancreatic cancers both in vitro and in vivo. Int. J. Cancer 94, 370-376
13. Barak, Y., Nelson, M. C, Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., and Evans, R. M. (1999) PPAR7 is required for placental, cardiac, and adipose tissue development. Mol. Cell 4, 585-595
14. Ohta, K., Endo, T., Haraguchi, K., Hershman, J. M., and Onaya, T. (2001) Ligands for peroxisome proliferator-activated receptor 7 inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 86, 2170-2177
15. Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C, Fletcher, J. A., Hlatky, L., Hahnfeldt, P., Folkman, J., and Kaipainen, A. (2002) PPAR7 ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Invest. 110, 923-932
16. Foster, K. W., Frost, A. R., McKie-Bell, P., Lin, C Y., Engler, J. A., Grizzle, W. E., and Ruppert, J. M. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60, 6488-6495
17. Foster, K. W., Ren, S., Louro, I. D., Lobo-Ruppert, S. M., McKie-Bell, P., Grizzle, W., Hayes, M. R., Broker, T. R., Chow, L. T., and Ruppert, J. M. (1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10, 423-434
18. Wang, N, Liu, Z. H, Ding, F., Wang, X. Q., Zhou, C. N, and Wu, M. (2002) Down-regulation of gut-enriched Krüppel-like factor expression in esophageal cancer. World J. Gastroenterol. 8, 966-970
19. Wei, D., Kanai, M., Huang, S., and Xie, K. (2006) Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27, 23-31
20. Ohnishi, S., Ohnami, S., Laub, F., Aoki, K., Suzuki, K., Kanai, Y., Haga, K., Asaka, M., Ramirez, F., and Yoshida, T. (2003) Down-regulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 308, 251-256
21. Hu, W., Hofstetter, W. L., Li, H., Zhou, Y., He, Y., Pataer, A., Wang, L., Xie, K., Swisher, S. G., and Fang, B. (2009) Putative tumor-suppressive function of Krüppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res. 15, 5688-5695
22. Guan, H., Xie, L., Leithäuser, F., Flossbach, L., Möller, P., Wirth, T., and Ushmorov, A. (2010) KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood 116, 1469-1478
23. Dang, D. T., Chen, X., Feng, J., Torbenson, M., Dang, L. H., and Yang, V. W. (2003) Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenicity. Oncogene 22, 3424-3430
24. Rageul, J., Mottier, S., Jarry, A., Shah, Y., Théoleyre, S., Masson, D., Gonzalez, F. J., Laboisse, C. L., and Denis, M. G. (2009) KLF4-dependent, PPAR7-induced expression of GPA33 in colon cancer cell lines. Int. J. Cancer 125, 2802-2809
25. Cekanova, M., Lee, S. H., McEntee, M. F., and Baek, S. J. (2010) MCC-555-induced NAG-1 expression is mediated in part by KLF4. Eur. J. Pharmacol. 637, 30-37
26. Zhou, Q., Hong, Y., Zhan, Q., Shen, Y., and Liu, Z. (2009) Role for Krüppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Res. 69, 8284-8292
27. Burstein, H. J., Demetri, G. D., Mueller, E., Sarraf, P., Spiegelman, B. M., and Winer, E. P. (2003) Use of the peroxisome proliferator-activated receptor (PPAR) 7 ligand troglitazone as treatment for refractory breast cancer: a phase II study. Breast Cancer Res. Treat. 79, 391-397
28. Koeffler, H. P. (2003) Peroxisome proliferator-activated receptor 7 and cancers. Clin. Cancer Res. 9, 1-9
29. Ming, M., Yu, J. P., Meng, X. Z., Zhou, Y. H, Yu, H. G., and Luo, H. S. (2006) Effect of ligand troglitazone on peroxisome proliferator-activated receptor 7 expression and cellular growth in human colon cancer cells. World J. Gastroenterol. 12, 7263-7270
30. 2 up-regulates Krüppel-like factor 4 expression independently of peroxisome proliferator-activated receptor 7 by activating the mitogen-acti-vated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Mol. Pharmacol. 68, 1203-1213
31. Papi, A., Rocchi, P., Ferreri, A. M., and Orlandi, M. (2010) RXR7 and PPAR7 ligands in combination to inhibit proliferation and invasiveness in colon cancer cells. Cancer Lett. 297, 65-74
32. Rowland, B. D., Bernards, R., and Peeper, D. S. (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 7, 1074-1082
33. Rowland, B. D., and Peeper, D.S. (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev. Cancer 6, 11-23